Matthias Dürst

16PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersMain group metal chemistryMolecular targetsPsychosocial aspects of childbirth and perinatal mental healthEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 14, 2024
Accuracy of GynTect® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study.

Heike Hoyer, Cornelia Scheungraber, Grit Mehlhorn

|Aug 12, 2023
Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal Study.

Heike Hoyer, Claudia Stolte, Gerd Böhmer

|Jun 24, 2022
Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.

Jana Hildebrandt, Norman Häfner, Helmar Görls

|May 14, 2022
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.

Jana Hildebrandt, Norman Häfner, Daniel Kritsch

|Jul 20, 2021
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance.

Heike Hoyer, Grit Mehlhorn, Cornelia Scheungraber

|Jun 24, 2021
Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.

Michael C J Quinn, Karen McCue, Wei Shi

Pageof 3

Frequent Collaborators

7 joint publications

Norman Häfner

3 joint publications

Martina Schmitz

2 joint publications

Wolfgang Weigand

2 joint publications

Thilo Dörk